PV EAEU 1969

Way back in the former USSR, the Department of registration, systematization and expedited reporting of drug side effects pioneered drug efficacy and safety monitoring.

2001

Biomapas is established and conducts its first BE studies

2002

Phase I-IV Clinical Trials are initiated

2003

First studies performed in the CIS region.

2004

First PK/PD Studies with Biologicals/Biosimilars.

2005

The Pharmacovigilance department is established.

2009

The Regulatory Affairs department is established.

2011

Biomapas adds Medical Devices services to its portfolio and completes first projects.

2012

Biomapas completes the ISO 9001:2008 to ensure high-quality services for its clients.

2013

The launch of Clinical Safety and Medical Monitoring services

2014

New offices open up in Russia and Georgia.

2015

New office opens up in Switzerland.

2016

New office opens up in Ukraine.

2017

Integrated ISO 9001:2015 and ISO 13485:2016

2018

New office opens up in Sweden.

2019

New office opens up in Poland.

2020

New office opens up in Kazakhstan.

2020

Biomapas adds Medical Information to its portfolio and consolidates its position as a partner from Early development to Post-Marketing.

World Drug Safety Congress Europe

World Drug Safety Congress Europe

Let’s meet at the World Drug Safety Congress Europe 2023, an exciting drug safety safety event in Amsterdam, Netherlands.

SwedenBIO Summit

SwedenBIO Summit

Meet us at the international partnering event to discuss the key challenges in clinical development in December in Stockholm.

[cool-timeline layout=”default” skin=”default” date-format=”F j” icons=”YES” show-posts=”20″ order=”DESC” story-content=”full”]